M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Esperion Therapeutics, Inc. to acquire Corstasis Therapeutics
Announced Mar 3, 2026 · Closed Apr 2, 2026 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Esperion Therapeutics, Inc. (ESPR)
- Target
- Corstasis Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Apr 2, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Jefferies
- To the target
- PJT Partners
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations